Metastatic spinal cord compression (update)
Closed for comments This consultation ended on at Request commenting lead permission
3 What the guideline will cover
3.1 Groups that will be covered
3.1.1 Adults with suspected or confirmed metastatic spinal disease and suspected or confirmed direct malignant infiltration of the spine.
3.1.2 Adults with suspected or confirmed spinal cord or nerve root compression because of metastatic spinal disease or direct malignant infiltration of the spine.
3.2 Groups that will not be covered
3.2.1 Adults with spinal cord compression because of primary tumours of the spinal cord, meninges or nerve roots.
3.2.2 Adults with spinal cord compression because of non-malignant causes.
3.2.3 Adults with primary bone tumours of the spinal column.
3.2.4 Children and young people under the age of 18.
3.3 Settings that will be covered
3.3.1 All settings where NHS commissioned care is provided.
3.4 Key areas that will be covered
We will look at evidence in the areas below when developing the guideline, but it may not be possible to make recommendations in all the areas.
3.4.1 Information and support
3.4.2 Service configuration and delivery
configuration of services and delivery arrangements for investigations and referral
configuration of services and delivery arrangements for management
3.4.3 Recognition
symptoms and signs of spinal metastatic malignant disease or direct malignant infiltration of the spine
symptoms and signs of spinal cord compression
3.4.4 Investigations
radiological imaging techniques in diagnosis
radiological imaging techniques to guide management
3.4.5 Prognostic tools
scoring systems to determine spinal instability
scoring systems to determine survival
3.4.6 Treatment
pain management
techniques or methods of immobilisation
bisphosphonate agents
radiotherapy (both fractionated and unfractionated)
invasive interventions such as vertebroplasty, kyphoplasty, ablation and surgery
corticosteroid therapy
3.5 Areas that will not be covered
3.5.1 Rehabilitation after treatment for spinal cord compression
3.5.2 Systemic oncological treatment
3.6 Related NICE guidance
Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain (2021) NICE guideline NG193
COVID-19 rapid guideline: delivery of radiotherapy (2021) NICE guideline NG162
Suspected cancer: recognition and referral (last updated 2021) NICE guideline NG12
Low back pain and sciatica in over 16s: assessment and management (last updated 2020) NICE guideline NG59
Neuropathic pain in adults: pharmacological management in non-specialist settings (last updated 2020) NICE guideline CG173
Lung cancer: diagnosis and management (2019) NICE guideline NG122
Prostate cancer: diagnosis and management (2019) NICE guideline NG131
Myeloma: diagnosis and management (last updated 2018) NICE guideline NG35
Advanced breast cancer: diagnosis and treatment (last updated 2017) NICE guideline CG81
Palliative care for adults: strong opioids for pain relief (last updated 2016) NICE guideline CG140
Percutaneous insertion of craniocaudal expandable implants for vertebral compression fracture (2016) NICE interventional procedure guidance IPG568
Pressure ulcers: prevention and management (2014) NICE guideline CG179
Urinary incontinence in neurological disease: assessment and management (2012) NICE guideline CG148
Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours (2012) NICE technology appraisal guidance TA265
Metastatic malignant disease of unknown primary origin in adults: diagnosis and management (2010) NICE guideline CG104
Faecal incontinence in adults: management (2007) NICE guideline CG49
Percutaneous cementoplasty for palliative treatment of bony malignancies (2006) NICE interventional procedure guidance IPG179
Balloon kyphoplasty for vertebral compression fractures (2006) NICE interventional procedure guidance IPG166
Percutaneous vertebroplasty (2003) NICE interventional procedure guidance IPG12
3.7 Related NICE guidance in development
Rehabilitation for chronic neurological disorders including traumatic brain injury. NICE guideline. Publication expected August 2023.
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults. NICE guideline. Publication expected November 2021.
Radiofrequency ablation for palliation of painful spinal metastases. NICE interventional procedure guidance. Publication date to be confirmed.
3.8 NICE guidance that will be updated by this guideline
Metastatic spinal cord compression in adults: risk assessment, diagnosis and management (2008) NICE guideline CG75
3.9 NICE guidance about the experience of people using NHS services
NICE has produced the following guidance on the experience of people using the NHS. This guideline will not include additional recommendations on these topics unless there are specific issues related to metastatic spinal cord compression:
Medicines optimisation (2015) NICE guideline NG5
Patient experience in adult NHS services (2012) NICE guideline CG138
Service user experience in adult mental health (2011) NICE guideline CG136
Medicines adherence (2009) NICE guideline CG76
3.10 Economic aspects
We will take economic aspects into account when making recommendations. We will develop an economic plan that states for each review question (or key area in the scope) whether economic considerations are relevant, and if so whether this is an area that should be prioritised for economic modelling and analysis. We will review the economic evidence and carry out economic analyses, using an NHS and personal social services (PSS) perspective, as appropriate.
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions